Evidence map›Paper›PMID 41255770›Full record

ArticleFrontiers in pediatrics2025

Machine learning identifies immune-perinatal predictors of infantile hemangioma.

Dongdong Wu, Neng Wan

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dongdong WuDepartment of Burn and Plastic Surgery, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
Neng WanDepartment of Burn and Plastic Surgery, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infantile hemangioma (IH), the most common vascular tumor of infancy, exhibits hallmark features of immune and inflammatory dysregulation. While most cases are self-limiting, a subset progresses with potentially severe complications. Despite its benign classification, IH offers a unique model to investigate immune-mediated mechanisms in early tumorigenesis. However, risk stratification models incorporating immune-inflammatory markers remain underdeveloped. Methods: A total of 1,466 infants and young children were enrolled, including 81 with IH. Comprehensive perinatal, clinical, and laboratory data were collected. Candidate risk factors were identified using logistic regression. Four machine learning algorithms-XGBoost, Random Forest, Support Vector Machine, and k-Nearest Neighbors-were employed to construct predictive models. Model performance was assessed through internal and external validation. SHapley Additive exPlanations (SHAP) were applied to interpret feature contributions and immune-inflammatory signatures. Results: Key risk factors included prematurity, multiple gestation, low birth weight, and elevated levels of VEGF, CRP, and SAA-markers linked to inflammation and immune activation. The XGBoost model achieved superior performance, with an AUC of 0.952 (training), 0.935 (internal validation), and 0.870 (external validation). SHAP analysis highlighted SAA, VEGF, and low birth weight as the most influential predictors, reflecting a critical link between innate immune dysregulation and IH development. Conclusion: This study presents a robust, interpretable machine learning model that leverages immune-perinatal features to predict IH risk. Our findings support the notion that IH may serve as a paradigm for inflammation-associated vascular tumorigenesis, with implications for early detection and personalized intervention strategies in immune-driven neoplasms.

Indexed as

immune-inflammatory markerinfantile hemangiomamachine learningrisk factorXGBoost

Identifiers

PMID41255770
PMCPMC12620500

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.